Evaxion Biotech A/S R & D Day Transcript
(technical difficulty) during the past 1.5 years. So we are super excited to share this with everyone. I would like to say that we have some Q&A sessions organized for each session here. So we will have 3 of those, and we really encourage people also online. To ask the questions, please write them. We will not do it with audio, but please write in the messaging device in there and we will read them out loud and try and answer the best possible and also for the crowd here, feel free to ask questions, we would like to have a nice discussion.
So [at Evaxion,] what are we doing? We are doing immunotherapy, and we really aspire to lead the exploration of AI in developing new vaccines, and that goes for both immuno-oncology and also for the infectious disease area. So today, we have a few examples of -- in the oncology arm of the company. And then we also have a few examples in the infectious disease area. So what we will be talking about today? The highlight of today is our platform, which is a vaccine platform developed in-house. And it's a DNA platform that has been
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
